Arcadia Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

• Arcadia Biosciences Inc RKDA.OQ reported quarterly adjusted earnings of $1.90​​ per share for the quarter ended March 31, higher than the same quarter last year, when the company reported EPS of $-1.78. The lone analyst forecast for the quarter was for a loss of 98 cents per share.

• Revenue fell 4.4% to $1.20 million from a year ago; analysts expected $1.30 million.

• Arcadia Biosciences Inc's reported EPS for the quarter was $1.90​.

• The company reported quarterly net income of $2.6 million.

• Arcadia Biosciences Inc shares had risen by 44.8% this quarter and lost 27.4% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," no "hold" and no "sell" or "strong sell." The average consensus recommendation for the food processing peer group is also "buy"

• Wall Street's median 12-month price target for Arcadia Biosciences Inc is $12.00

This summary was machine generated from LSEG data May 8 at 02:06 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)